Showing 1481-1490 of 9336 results for "".
- Skin Cancer-related Mutations Higher in the UK Than Singaporehttps://practicaldermatology.com/news/skin-cancer-related-mutations-higher-in-the-uk-than-singapore/2461909/People in the UK have facial skin that is far more DNA damaged from the sun than people in Singapore, explaining the far higher risk of developing basal and squamous cell carcinomas in the UK, new research suggests. When researchers from the Wellcome Sanger Institute and their collaborators at the…
- Replimune, Incyte Enter Into Clinical Trial Collaboration And Supply Agreement To Evaluate RP1 and INCB99280 in CSCChttps://practicaldermatology.com/news/replimune-incyte-enter-into-clinical-trial-collaboration-and-supply-agreement-to-evaluate-rp1-and-incb99280-in-cscc/2461908/Replimune Group, Inc. and Incyte are collaborating to a study RP1 in combination with INCB99280, Incyte’s small molecule oral PD-L1 inhibitor, in cutaneous squamous cell carcinoma (CSCC) and in other cancer types, the companies report. RP1 is based on a proprietary new strain of herpes simplex vir…
- RoC Skincare Expands The Look Forward Project to Instill Optimism Among the Next Generationhttps://practicaldermatology.com/news/roc-skincare-expands-the-look-forward-project-to-instill-optimism-among-the-next-generation/2461905/RoC Skincare is expanding The RoC Look Forward Project in partnership with Sarah Jessica Parker. The initiative was first launched in 2022 to celebrate the power of optimism and its positive impact on long-term health and wellbeing. Now, the Look Forward Project is supporting the next generatio…
- Another FDA Nod for SkinStylus Microneedling Device: Facial Acne Scarshttps://practicaldermatology.com/news/another-fda-nod-for-skinstylus-microneedling-device-facial-acne-scars/2461904/The U.S. Food and Drug Administration (FDA) has cleared The Beauty Health Company’s SkinStylus microneedling device for use on facial acne scarring in Fitzpatrick skin types I, II, and III in patients aged 22 years and older. SkinStylus is already FDA-cleared to improve the appearance of surgical …
- Golfers Face Higher Risk for Skin Cancerhttps://practicaldermatology.com/news/golfers-face-higher-risk-for-skin-cancer/2461902/New research from the University of South Australia shows that golfers have a higher risk of skin cancer when compared to the general population. Fully 27% of golfers – or one in four – had been diagnosed with skin cancer, as compared with 7% of the general population, indicating 2.4 times greater…
- Abeona Therapeutics Submits Briefing Package for Pre-BLA Meeting with FDA in August 2023https://practicaldermatology.com/news/abeona-therapeutics-submits-briefing-package-for-pre-bla-meeting-with-fda-in-august-2023/2461901/Abeona Therapeutics Inc. completed the submission of the briefing package to the U.S. Food and Drug Administration (FDA) for the Company’s pre-Biologics License Application (BLA) meeting in August 2023. The purpose of the meeting is to discuss the format, content, and acceptability of the anticip…
- US FDA Grants Breakthrough Device Designation to Marpe's Dermatology Screening Systemhttps://practicaldermatology.com/news/us-fda-grants-breakthrough-device-designation-to-marpes-dermatology-screening-system/2461900/The US Food and Drug Administration (FDA) has granted Breakthrough Device designation to Marpe Technologies full-body Dermatology Screening System. The Marpe System is designed to acquire and analyze total body images to support the identification of malignant and pre-malignant lesions, with a par…
- Lupus Foundation of America Awards Five Summer Fellowship Grantshttps://practicaldermatology.com/news/lupus-foundation-of-america-awards-five-summer-fellowship-grants/2461899/The Lupus Foundation of America announced five recipients of the 2023 Gina M. Finzi Memorial Student Summer Fellowship Program. The Gina M. Finzi Memorial Student Summer Fellowship Program, established in 1984, was created to honor Gina M. Finzi, the late daughter of former Lupus Foundation of Ame…
- Reinforcement Learning Model May Boost AI Skin Cancer Diagnosis Accuracyhttps://practicaldermatology.com/news/reinforcement-learning-model-may-boost-ai-skin-cancer-diagnosis-accuracy/2461897/Artificial intelligence (AI) is already being used to diagnose skin cancer, but so far, it can’t keep pace with the complex decision-making of doctors in practice. Now, an international research team is developing a learning method in which greater accuracy in AI results can be achieved by incorpo…
- More Screening Won’t Solve Racial Disparities in Melanoma Outcomeshttps://practicaldermatology.com/news/more-screening-wont-solve-racial-disparities-in-melanoma-outcomes/2461894/Increased skin cancer screening in individuals with skin of color is not sufficient to address racial disparities in melanoma survival rates, according to a new study in JAMA Dermatology. “In this study, we asked whether screening could address this disparity by helping detect melanoma early,” say…